Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

J&J EVP Timothy Schmid Sells Nearly $9M in Company Stock Amid Bull Run

Guavy AI Editorial Team
Instruments
JNJ
Share

Timothy Schmid, Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson (JNJ), sold company stock totaling approximately $9.23 million on September 2, 2026.

The transactions involved the sale of 33,597 shares of common stock at a price of $274.74 per share, with Schmid previously acquiring an equal number of shares through the exercise of employee stock options.

This sale came as JNJ stock trades near its 52-week high of $281.07, with shares up 59% over the past year.

More on Stocks

Stocks just now

Disney Takes Another Shot at Tomorrowland

Stocks just now

Lea Salonga's Star Shines Bright on Hollywood Walk of Fame

Stocks just now

Salesforce Scoops Up AI Customer Support Firm Fin for $3.6 Billion

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy